Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy

Experimental and Therapeutic Medicine

Volumn 4, Issue 3, 2012, Pages 452-458

  Baba, Yasutaka ^a   Jun Ichiro, Sonoda ^a   Hayashi, Sadao ^a   Tosuji, Nanako ^a   Sonoda, Shunro ^a   Makisumi, Kanro ^a   Nakajo, Masayuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Antioxidant; Green tea tablet; Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Metastatic liver cancer; Oxidative stress

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CDDP; CHOLINESTERASE; CISPLATIN; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GREEN TEA EXTRACT; GREEN TEA POLYPHENOL; POLYPHENOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG ISOLATION; ERYTHROCYTE COUNT; FEMALE; HEPATIC ARTERY; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OXIDATIVE STRESS;

EID: 84863976493     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.602     Document Type: Article

References (32)

1. Rice-Evans C: Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med 220: 262-266, 1999.
2. Wiseman SA, Balentine DA and Frei B: Antioxidants in tea. Crit Rev Food Sci Nutr 37: 705-718, 1997.
3. Muto S, Yokoi T, Gondo Y, et al: Inhibition of benzo[a]pyreneinduced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice. Carcinogenesis 20: 421-424, 1999.
4. Yang GY, Liao J, Kim K, Yurkow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998.
5. Okabe S, Ochiai Y, Aida M, et al: Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn J Cancer Res 90: 733-739, 1999.
6. Setiawan VW, Zhang ZF, Yu GP, et al: Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 92: 600-604, 2001.
7. Rao DN, Ganesh B, Dinshaw KA and Mohandas KM: A case-control study of stomach cancer in Mumbai, India. Int J Cancer 99: 727-731, 2002.
8. Masuda M, Suzui M and Weinstein IB: Effects of epigallo -catechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7: 4220-4229, 2001.
9. Masuda M, Suzui M, Lim JT and Weinstein IB: Epigallocatechin- 3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 9: 3486-3491, 2003.
10. Liang YC, Lin-Shiau SY, Chen CF and Lin JK: Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem 67: 55-65, 1997.
11. Liang G, Tang A, Lin X, et al: Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 37: 111-123, 2010.
12. Seki H, Ozaki T and Shiina M: Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit. AJR Am J Roentgenol 190: 111-120, 2008.
13. Sonoda J, Koriyama C, Yamamoto S, et al: HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci 95: 596-601, 2004.
14. Mantovani G, Macciò A, Madeddu C, et al: Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med (Berl) 81: 664-673, 2003.
15. Conklin KA: Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 3: 294-300, 2004.
16. Lamson DW and Brignall MS: Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 4: 304-329, 1999.
17. Quiles JL, Huertas JR, Battino M, Mataix J and Ramírez-Tortosa MC: Antioxidant nutrients and adriamycin toxicity (Review). Toxicology 180: 79-95, 2002.
18. Moss RW: Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther 5: 63-82, 2006.
19. Lamson DW and Brignall MS: Antioxidants and cancer, part 3: quercetin. Altern Med Rev 5: 196-208, 2000.
20. Lamson DW and Brignall MS: Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev 5: 152-163, 2000.
21. Lamson DW and Brignall MS: Natural agents in the prevention of cancer. Part 1: human chemoprevention trials. Altern Med Rev 6: 7-19, 2001.
22. Pathak AK, Bhutani M, Guleria R, et al: Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am Coll Nutr 24: 16-21, 2005.
23. Pathak AK, Singh N, Khanna N, Reddy VG, Prasad KN and Kochupillai V: Potentiation of the effect of paclitaxel and carboplatin by antioxidant mixture on human lung cancer h520 cells. J Am Coll Nutr 21: 416-421, 2002.
24. Drisko JA, Chapman J and Hunter VJ: The use of antioxidant therapies during chemotherapy (Review). Gynecol Oncol 88: 434-439, 2003.
25. Kanaoka Y, Inagaki E, Hamanaka S, Masaki H and Tanemoto K: Analysis of reactive oxygen metabolites (ROMs) after cardiovascular surgery as a marker of oxidative stress. Acta Med Okayama 64: 323-330, 2010.
26. Cesarone MR, Belcaro G, Carratelli M, et al: A simple test to monitor oxidative stress. Int Angiol 18: 127-130, 1999.
27. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato and Ito S: Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol 11: 218-224, 2007.
28. Kono S, Ikeda M, Tokudome S and Kuratsune M: A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 79: 1067-1074, 1988.
29. Ohno Y, Wakai K, Genka K, et al: Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Jpn J Cancer Res 86: 1027-1034, 1995.
30. Imai K, Suga K and Nakachi K: Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26: 769-775, 1997.
31. Kimura M, Umegaki K, Kasuya Y, Sugisawa A and Higuchi M: The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 56: 1186-1193, 2002.
32. Koren E, Kohen R and Ginsburg I: Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells. Exp Biol Med (Maywood) 235: 689-699, 2010.